8 results match your criteria: "Duke University Department of Neurology[Affiliation]"
Ann Neurol
November 2024
Department of Translational Neuroscience, Barrow Neurological Institute, Phoenix, AZ, USA.
Nat Sci Sleep
August 2023
Global Medical Affairs, Jazz Pharmaceuticals, Philadelphia, PA, USA.
Purpose: Idiopathic hypersomnia is a debilitating neurologic sleep disorder characterized by excessive daytime sleepiness, sleep inertia, and prolonged sleep. Its impact on patients' quality of life and daily functioning has not been fully elucidated. The Real World Idiopathic Hypersomnia Outcomes Study (ARISE) evaluated the daily functioning, relationships, cognition, emotional well-being, and productivity/employment of participants with idiopathic hypersomnia.
View Article and Find Full Text PDFNeurology
April 2023
From the Duke University School of Medicine (J.B.L., B.G.H.); Duke University Fuqua School of Business (J.B.L.); Duke University Department of Population Health Sciences (M.N.H., A.G.C., B.G.H.); Duke University Health System (J.B.); Duke University Department of Medicine (J.B.); and Duke University Department of Neurology (M.W.L.), Durham, NC.
Background And Objectives: Patients of low individual socioeconomic status (SES) are at a greater risk of unfavorable health outcomes. However, the association between neighborhood socioeconomic deprivation and health outcomes for patients with neurologic disorders has not been studied at the population level. Our objective was to determine the association between neighborhood socioeconomic deprivation and 30-day mortality and readmission after hospitalization for various neurologic conditions.
View Article and Find Full Text PDFCase Rep Neurol Med
January 2022
Duke University Department of Neurology, Duke University Medical Center, 2905 40 Medicine Circle, Durham, NC 27710, USA.
A 51-year-old man with known Leber's hereditary optic neuropathy (LHON) presented with worsening lower extremity weakness and numbness. Following an episode of myelopathy two years before, he had been ambulating with a walker but over two weeks became wheelchair bound. He also developed a sensory level below the T4 dermatome to light touch, pinprick, and vibration.
View Article and Find Full Text PDFCase Rep Neurol Med
December 2020
Duke University Department of Neurology, Duke University Medical Center 2905, 40 Medicine Circle, Durham, NC 27710, USA.
A 76-year-old Caucasian woman initially presented to the Duke Memory Disorders clinic with a 9-month history of a rapid decline in cognitive, motor, and neuropsychiatric function. On initial presentation, the patient required assistance with activities of daily living. On neurological examination, she was found to have Gerstmann's syndrome along with appendicular apraxia.
View Article and Find Full Text PDFLife Sci Soc Policy
October 2020
Duke University Department of Neurology, 311 Research Drive, Durham, North Carolina, 27710-2900, USA.
In the United States alone, the prevalence of AD is expected to more than double from six million people in 2019 to nearly 14 million people in 2050. Meanwhile, the track record for developing treatments for AD has been marked by decades of failure. But recent progress in genetics, neuroscience and gene editing suggest that effective treatments could be on the horizon.
View Article and Find Full Text PDFGeriatrics (Basel)
December 2018
Duke University Department of Orthopaedic Surgery, Durham, NC 27710, USA.
Muscle health is recognized for its critical role in the functionality and well-being of older adults. Readily accessible, reliable, and inexpensive methods of measuring muscle health are needed to advance research and clinical care. In this prospective, blinded study, 27 patients underwent quantitative muscle ultrasound (QMUS), standard electrical impedance myography (sEIM), and handheld electrical impedance myography (hEIM) of the anterior thigh musculature by two independent examiners.
View Article and Find Full Text PDFImmune checkpoint inhibitors have improved patient survival outcomes in a variety of advanced malignancies. However, they can cause a number of immune-related adverse effects (irAEs) through lymphocyte dysregulation. Central nervous system (CNS) irAEs are rare, but as the number of indications for checkpoint inhibitors increases, there has been emergence of CNS immune-mediated disease among cancer patients.
View Article and Find Full Text PDF